摘要
目的研究维心康泰对高脂血症大鼠血液流变性及血脂的影响。方法用脂肪乳制备高脂血症大鼠模型,比较维心康泰与多烯康对高脂血症大鼠血液流变学及血脂的影响。结果维心康泰40mg/kg及160mg/kg与多烯康80mg/kg均能明显降低高脂血症大鼠的血液粘度,明显降低血清中总胆固醇(TC)和甘油三酯(TG)的含量,显著提高高密度脂蛋白(HDL)及(HDL/TC)的比值(P<0.01),且作用强于多烯康;但对红细胞压积(HCT)和血沉(ESR)无明显影响。结论维心康泰具有改善血液流变学、调血脂和抗动脉粥样硬化的作用。
Objective:To observe the effects of Weixinkangtai (WXKT) capsule on the hemorheology and bloodlipid in hyperlipidemia rats. Methods : The model of hyperlipidemia rats was made by fatty emulsion, to compare the effects of Weixinkangtai capsule and Duoxikang capsule on the hemorheology and blood-lipid in hypedipidemia rats. Results: Weixinkangtai 40mg/kg, 160mg/kg and Duoxikang 80mg/kg can reduce the bloodviseosity observably in hyperlipidemia rats( P 〈 0.01 ). The content of total cholesterol(TC) and triglyceride (TG) in serum were re- duced evidently ( P 〈0.01 ) , the content of high density lipoprotein (HDL) and the ratio of HDL and TC (HDL/TC) were increased observably ( P 〈 0.01 ) ; the process of Weixinkangtai capsule is mightier than DuoXiKang capsule ( P 〈0.01 or P 〈 0. 05 ) ; but its has not effects for the the hematocrit (HCT) and erythroeyte sedimentation rate (ESR). Conclusion: Weixinkangtai capsule has the action of ameliorating hemorheology, adjusting bloodlipid.
出处
《中药药理与临床》
CAS
CSCD
北大核心
2005年第6期70-72,共3页
Pharmacology and Clinics of Chinese Materia Medica
关键词
维心康泰胶囊
高脂血症
大鼠
血液流变学
血脂
Weixinkangtai capsule (维心康泰胶囊)
hyperlipidemia
hemorheology
bloodlipid